BiotechTube

Ramucirumab + Paclitaxel + Placebo

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Gastroesophageal Junction Adenocarcinoma

Conditions

Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma

Trial Timeline

Mar 2, 2017 → Apr 12, 2021

NCT ID
NCT02898077

About Ramucirumab + Paclitaxel + Placebo

Ramucirumab + Paclitaxel + Placebo is a phase 3 stage product being developed by Eli Lilly for Gastroesophageal Junction Adenocarcinoma. The current trial status is completed. This product is registered under clinical trial identifier NCT02898077. Target conditions include Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT02898077Phase 3Completed

Competing Products

20 competing products in Gastroesophageal Junction Adenocarcinoma

See all competitors
ProductCompanyStageHype Score
Ramucirumab + Paclitaxel + Sacituzumab Tirumotecan + Rescue Medications + HER3-DXdDaiichi SankyoPhase 1/2
41
Trastuzumab DeruxtecanDaiichi SankyoPhase 2
52
zolbetuximabAstellas PharmaPre-clinical
23
zolbetuximab + placebo + oxaliplatin + folinic acid + fluorouracilAstellas PharmaPhase 3
77
zolbetuximabAstellas PharmaPre-clinical
23
epirubicin + oxaliplatin + capecitabine + zolbetuximabAstellas PharmaPhase 2
52
zolbetuximab + oxaliplatin + capecitabine + placeboAstellas PharmaPhase 3
77
FamotidineAstellas PharmaPhase 2/3
65
zolbetuximab + Pembrolizumab + Capecitabine + Oxaliplatin + Folinic acid (leucovorin or local equivalent) + 5-fluorouracil (5-FU) + PlaceboAstellas PharmaPhase 3
77
Gentuximab + PaclitaxelSun PharmaceuticalPhase 1/2
41
E3810 + E3810 + PlaceboEisaiPhase 3
77
Rabeprazole ER + RanitidineEisaiPhase 3
77
E3710 + E3710EisaiPhase 1
33
rabeprazole and pantoprazoleEisaiApproved
85
Rabeprazole 20 mgEisaiPhase 2
52
rabeprazole sodiumEisaiPhase 2
52
RABEPRAZOLE SODIUM + RABEPRAZOLE SODIUMEisaiPhase 3
77
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
77
rabeprazole sodium + PlaceboEisaiPhase 3
77
Rabeprazole + Rabeprazole + Rabeprazole + RabeprazoleEisaiPhase 3
77

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved
85
Olanzapine + PlaceboApproved
85
exenatide and sitagliptin + exenatide and placeboApproved
85
Tirzepatide + PlaceboApproved
85
tadalafilApproved
85